Literature DB >> 7810518

Renal replacement therapy in the United States: data from the United States Renal Data System.

L Y Agodoa1, P W Eggers.   

Abstract

This report is a summary of the discussion on the United States Renal Data System and its data contents, as presented at the Symposium on World Renal Registries on December 10, 1993. The United States Rental Data System is a national database that collects and analyzes information on the incidence, prevalence, morbidity, and mortality, as well as the modalities of therapy of patients with end-stage renal disease (ESRD) in the United States. The database is funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Data on the patients are provided by the Health Care Financing Administration Medicare Program. The coordinating center for the database, operated through a contract mechanism, was formerly at the Urban Institute in Washington, DC, but is currently located at the University of Michigan, Ann Arbor, MI. The data system contains information on over 462,000 patients with more than 4 million dialysis records, 2.3 million inpatient records, 94,000 transplant reports, and more than 290,000 follow-up reports. The incidence rate of ESRD is approximately 180 per million population. However, the rate is higher in African-Americans (430) and Native Americans (281) than in whites (153) and Asian/Pacific Islanders (133). The gross mortality rate of the entire ESRD population is approximately 168 deaths per 1,000 patient-years at risk. The death rate is higher in diabetic than in nondiabetic ESRD patients. It is also higher in ESRD patients older than 65 years (357) than in patients in the 45- to 64-year-old age group (158) or those in the 20- to 44-year-old age group (62).

Entities:  

Mesh:

Year:  1995        PMID: 7810518     DOI: 10.1016/0272-6386(95)90638-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

3.  Role of podocyte B7-1 in diabetic nephropathy.

Authors:  Paolo Fiorina; Andrea Vergani; Roberto Bassi; Monika A Niewczas; Mehmet M Altintas; Marcus G Pezzolesi; Francesca D'Addio; Melissa Chin; Sara Tezza; Moufida Ben Nasr; Deborah Mattinzoli; Masami Ikehata; Domenico Corradi; Valerie Schumacher; Lisa Buvall; Chih-Chuan Yu; Jer-Ming Chang; Stefano La Rosa; Giovanna Finzi; Anna Solini; Flavio Vincenti; Maria Pia Rastaldi; Jochen Reiser; Andrzej S Krolewski; Peter H Mundel; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

4.  Gender and living donor kidney transplantation.

Authors:  Neda Khalifeh; Walter H Hörl
Journal:  Wien Med Wochenschr       Date:  2011-03

5.  Mast cells: the forgotten cells of renal fibrosis.

Authors:  I S Roberts; P E Brenchley
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

6.  Allocation of initial modality for renal replacement therapy in Brazil.

Authors:  Mônica Viegas Andrade; Jaume Puig Junoy; Eli Iola Gurgel Andrade; Francisco de Assis Acurcio; Ricardo Sesso; Odilon Vanni de Queiroz; Daniele Araújo Szuster; Isabel Cristina Gomes; Alessandra Maciel Almeida; Mariangela Leal Cherchiglia
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

7.  Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.

Authors:  Masayuki Yamanouchi; Jan Skupien; Monika A Niewczas; Adam M Smiles; Alessandro Doria; Robert C Stanton; Andrzej T Galecki; Kevin L Duffin; Nick Pullen; Matthew D Breyer; Joseph V Bonventre; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2017-04-07       Impact factor: 10.612

8.  Six-year dialysis freedom in end-stage renal disease.

Authors:  Aamir Jalal Al Mosawi
Journal:  Clin Exp Nephrol       Date:  2009-05-30       Impact factor: 2.801

9.  Kidney disease in elderly minorities.

Authors:  Chamberlain I Obialo; Sharon Allison-Ottey
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

10.  Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.

Authors:  Jung Eun Lee; Tomohito Gohda; William H Walker; Jan Skupien; Adam M Smiles; Rita R Holak; Jackson Jeong; Kevin P McDonnell; Andrzej S Krolewski; Monika A Niewczas
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.